HCW Biologics (NASDAQ:HCWB) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of HCW Biologics (NASDAQ:HCWB – Free Report) from a sell rating to a hold rating in a report issued on Sunday. Separately, Maxim Group decreased their target price on HCW Biologics from $120.00 to $35.00 and set a “buy” rating for the company in a research report on Thursday, May […]
Wall Street Zen upgraded shares of HCW Biologics (NASDAQ:HCWB – Free Report) from a sell rating to a hold rating in a report issued on Sunday. Separately, Maxim Group decreased their target price on HCW Biologics from $120.00 to $35.00 and set a “buy” rating for the company in a research report on Thursday, May […]
